Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I trial of tideglusib in volunteers.

Trial Profile

Phase I trial of tideglusib in volunteers.

Phase of Trial: Phase I

Latest Information Update: 10 Mar 2009

At a glance

  • Drugs Tideglusib (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions
  • Sponsors Noscira
  • Most Recent Events

    • 10 Mar 2009 Tolerability results have been reported in a Noscira media release.
    • 18 Aug 2008 Status changed from recruiting to unconfirmed. According to a Neuropharma media release, a total of 140 subjects have received NP-031112 as of 31 Jul 08.
    • 12 May 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top